Since 1996, when new US federal regulations required researchers and institutional review boards (IRBs) to obtain exceptions from standard informed consent for studies involving patients with emergency or life-threatening conditions, IRBs have been reluctant to approve such research, causing a limited number of such studies to be conducted. But new recommendations that offer a template to help IRBs and researchers designing trials meet these regulations may help remedy this situation.